EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer: translational results from the randomised, crossover phase 3 trial AIO-PK0104
We aimed to identify molecular epidermal growth factor receptor (EGFR) tissue biomarkers in pancreatic cancer (PC) patients treated with the anti-EGFR agent erlotinib within the phase 3 randomised AIO-PK0104 study.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2013
|
| In: |
British journal of cancer
Year: 2012, Jahrgang: 108, Heft: 2, Pages: 469-476 |
| ISSN: | 1532-1827 |
| DOI: | 10.1038/bjc.2012.495 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/bjc.2012.495 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/bjc2012495 
|
| Verfasserangaben: | S. Boeck, A. Jung, R.P. Laubender, J. Neumann, R. Egg, C. Goritschan, U. Vehling-Kaiser, C. Winkelmann, L. Fischer von Weikersthal, M.R. Clemens, T.C. Gauler, A. Märten, S. Klein, G. Kojouharoff, M. Barner, M. Geissler, T.F. Greten, U. Mansmann, T. Kirchner and V. Heinemann |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1741403847 | ||
| 003 | DE-627 | ||
| 005 | 20220819040114.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 201127r20132012xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/bjc.2012.495 |2 doi | |
| 035 | |a (DE-627)1741403847 | ||
| 035 | |a (DE-599)KXP1741403847 | ||
| 035 | |a (OCoLC)1341382776 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Böck, Stefan |d 1977- |e VerfasserIn |0 (DE-588)129950580 |0 (DE-627)484977768 |0 (DE-576)297917978 |4 aut | |
| 245 | 1 | 0 | |a EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer |b translational results from the randomised, crossover phase 3 trial AIO-PK0104 |c S. Boeck, A. Jung, R.P. Laubender, J. Neumann, R. Egg, C. Goritschan, U. Vehling-Kaiser, C. Winkelmann, L. Fischer von Weikersthal, M.R. Clemens, T.C. Gauler, A. Märten, S. Klein, G. Kojouharoff, M. Barner, M. Geissler, T.F. Greten, U. Mansmann, T. Kirchner and V. Heinemann |
| 264 | 1 | |c 2013 | |
| 300 | |a 8 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a published online 20 November 2012 | ||
| 500 | |a Gesehen am 27.11.2020 | ||
| 520 | |a We aimed to identify molecular epidermal growth factor receptor (EGFR) tissue biomarkers in pancreatic cancer (PC) patients treated with the anti-EGFR agent erlotinib within the phase 3 randomised AIO-PK0104 study. | ||
| 534 | |c 2012 | ||
| 700 | 1 | |a Jung, A. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laubender, R. P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Neumann, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Egg, R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goritschan, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vehling-Kaiser, U. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Winkelmann, C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fischer von Weikersthal, L. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Clemens, M. R. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gauler, T. C. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Märten, Angela |d 1968- |e VerfasserIn |0 (DE-588)122240103 |0 (DE-627)081822456 |0 (DE-576)293167931 |4 aut | |
| 700 | 1 | |a Klein, S. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kojouharoff, G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Barner, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Geissler, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Greten, T. F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Mansmann, U. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kirchner, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Heinemann, V. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t British journal of cancer |d Edinburgh : Nature Publ. Group, 1947 |g 108(2013), 2, Seite 469-476 |h Online-Ressource |w (DE-627)320420094 |w (DE-600)2002452-6 |w (DE-576)103746854 |x 1532-1827 |7 nnas |a EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer translational results from the randomised, crossover phase 3 trial AIO-PK0104 |
| 773 | 1 | 8 | |g volume:108 |g year:2013 |g number:2 |g pages:469-476 |g extent:8 |a EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer translational results from the randomised, crossover phase 3 trial AIO-PK0104 |
| 856 | 4 | 0 | |u https://doi.org/10.1038/bjc.2012.495 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/bjc2012495 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20201127 | ||
| 993 | |a Article | ||
| 994 | |a 2013 | ||
| 998 | |g 122240103 |a Märten, Angela |m 122240103:Märten, Angela |p 12 | ||
| 999 | |a KXP-PPN1741403847 |e 3814685695 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"role":"aut","display":"Böck, Stefan","roleDisplay":"VerfasserIn","given":"Stefan","family":"Böck"},{"display":"Jung, A.","roleDisplay":"VerfasserIn","role":"aut","family":"Jung","given":"A."},{"family":"Laubender","given":"R. P.","display":"Laubender, R. P.","roleDisplay":"VerfasserIn","role":"aut"},{"roleDisplay":"VerfasserIn","display":"Neumann, J.","role":"aut","family":"Neumann","given":"J."},{"family":"Egg","given":"R.","display":"Egg, R.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","display":"Goritschan, C.","roleDisplay":"VerfasserIn","given":"C.","family":"Goritschan"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Vehling-Kaiser, U.","given":"U.","family":"Vehling-Kaiser"},{"role":"aut","display":"Winkelmann, C.","roleDisplay":"VerfasserIn","given":"C.","family":"Winkelmann"},{"given":"L.","family":"Fischer von Weikersthal","role":"aut","roleDisplay":"VerfasserIn","display":"Fischer von Weikersthal, L."},{"family":"Clemens","given":"M. R.","roleDisplay":"VerfasserIn","display":"Clemens, M. R.","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Gauler, T. C.","given":"T. C.","family":"Gauler"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Märten, Angela","given":"Angela","family":"Märten"},{"family":"Klein","given":"S.","display":"Klein, S.","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Kojouharoff, G.","given":"G.","family":"Kojouharoff"},{"family":"Barner","given":"M.","display":"Barner, M.","roleDisplay":"VerfasserIn","role":"aut"},{"display":"Geissler, M.","roleDisplay":"VerfasserIn","role":"aut","family":"Geissler","given":"M."},{"family":"Greten","given":"T. F.","display":"Greten, T. F.","roleDisplay":"VerfasserIn","role":"aut"},{"given":"U.","family":"Mansmann","role":"aut","roleDisplay":"VerfasserIn","display":"Mansmann, U."},{"roleDisplay":"VerfasserIn","display":"Kirchner, T.","role":"aut","family":"Kirchner","given":"T."},{"family":"Heinemann","given":"V.","display":"Heinemann, V.","roleDisplay":"VerfasserIn","role":"aut"}],"title":[{"title":"EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer","subtitle":"translational results from the randomised, crossover phase 3 trial AIO-PK0104","title_sort":"EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer"}],"note":["published online 20 November 2012","Gesehen am 27.11.2020"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"language":["eng"],"recId":"1741403847","name":{"displayForm":["S. Boeck, A. Jung, R.P. Laubender, J. Neumann, R. Egg, C. Goritschan, U. Vehling-Kaiser, C. Winkelmann, L. Fischer von Weikersthal, M.R. Clemens, T.C. Gauler, A. Märten, S. Klein, G. Kojouharoff, M. Barner, M. Geissler, T.F. Greten, U. Mansmann, T. Kirchner and V. Heinemann"]},"origin":[{"dateIssuedDisp":"2013","dateIssuedKey":"2013"}],"id":{"doi":["10.1038/bjc.2012.495"],"eki":["1741403847"]},"physDesc":[{"extent":"8 S."}],"relHost":[{"title":[{"title":"British journal of cancer","subtitle":"BJC","title_sort":"British journal of cancer"}],"disp":"EGFR pathway biomarkers in erlotinib-treated patients with advanced pancreatic cancer translational results from the randomised, crossover phase 3 trial AIO-PK0104British journal of cancer","note":["Gesehen am 27.10.25"],"type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320420094","language":["eng"],"pubHistory":["Volume 1, issue 1 (1 March 1947)-"],"titleAlt":[{"title":"BJC"}],"part":{"extent":"8","text":"108(2013), 2, Seite 469-476","volume":"108","issue":"2","pages":"469-476","year":"2013"},"origin":[{"publisherPlace":"Edinburgh ; Edinburgh","dateIssuedKey":"1947","publisher":"Nature Publ. Group ; Churchill Livingstone","dateIssuedDisp":"1947-"}],"id":{"zdb":["2002452-6"],"eki":["320420094"],"issn":["1532-1827"]},"physDesc":[{"extent":"Online-Ressource"}]}]} | ||
| SRT | |a BOECKSTEFAEGFRPATHWA2013 | ||